: 73% Blue Waterlock , , , 5 ,
In this review, we discuss the current knowledge on ROS production and its effects across various viral infections, including severe acute respiratory syndrome-coronavirus-2, influenza A virus, dengue virus, Zika virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections, to improve future therapeutic and preventive strategies for these infections
Selmani A, Seibert E, Tetyczka C, Kuehnelt D, Vidakovi I, Kornmueller K, Absenger-Novak M, Radatovi B, Vrek IV, Leitinger G, Frhlich E, BernkopSchnrch A, Roblegg E, Prassl R (2022) Thiolated chitosan conjugated liposomes for oral delivery of selenium nanoparticles
No standardized dosing protocol exists for Dihexa in human clinical medicine